Importantly, blocking the PD-1/PD-L1 axis partially reversed this inhibition, highlighting a potential therapeutic synergy between radiotherapy and immune checkpoint inhibitors to counteract tumor immune evasion. The gene discussed is CD274; the disease is neoplasm.